Facteurs de risque génétiques pour le cancer de la prostate
Med Sci (Paris), 20 5 (2004) 562-568
Published online: 2004-05-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Le cancer de la prostate, le cancer le plus fréquent chez l’homme en France
Pierre Francès, Tara Chalaye, Oumnia Karim, Omar Haj Amreir and Mélissandre BillaudotSoins Aides-Soignantes 21 (121) 26 (2024)
https://doi.org/10.1016/j.sasoi.2024.09.012
Recherche d’altérations des gènes de réparation de l’ADN dans le cancer de la prostate : mise au point pratique du Comité de cancérologie de l’association française d’urologie
G. Ploussard, J.-B. Beauval, R. Mathieu, et al.Progrès en Urologie 32 (3) 155 (2022)
https://doi.org/10.1016/j.purol.2021.12.007
Profil épidémiologique, diagnostique, thérapeutique et évolutif du cancer de la prostate au Togo
K. Tengue, T.M. Kpatcha, G. Botcho, et al.African Journal of Urology 22 (2) 76 (2016)
https://doi.org/10.1016/j.afju.2015.06.006
Prostate cancer: The main risk and protective factors – Epigenetic modifications
Mawussi Adjakly, Marjolaine Ngollo, Aslihan Dagdemir, et al.Annales d'Endocrinologie 76 (1) 25 (2015)
https://doi.org/10.1016/j.ando.2014.09.001
Factores de riesgo constitucionales en el cáncer de próstata
J. Ferrís-i-Tortajada, J. García-i-Castell, O. Berbel-Tornero and J.A. Ortega-GarcíaActas Urológicas Españolas 35 (5) 282 (2011)
https://doi.org/10.1016/j.acuro.2010.12.009
Constitutional risk factors in prostate cancer
J. Ferrís-i-Tortajada, J. García-i-Castell, O. Berbel-Tornero and J.A. Ortega-GarcíaActas Urológicas Españolas (English Edition) 35 (5) 282 (2011)
https://doi.org/10.1016/j.acuroe.2011.06.005
NPM : un nouvel acteur dans le cancer de la prostate ?
Claude Beaudoin, Sabrina Maquaire, Laurent Léotoing, et al.médecine/sciences 25 (1) 19 (2009)
https://doi.org/10.1051/medsci/200925119
Implications of insulin‐like growth factor‐I for prostate cancer therapies
Satoko Kojima, Masahiko Inahara, Hiroyoshi Suzuki, Tomohiko Ichikawa and Yuzo FuruyaInternational Journal of Urology 16 (2) 161 (2009)
https://doi.org/10.1111/j.1442-2042.2008.02224.x
La RNase L, un acteur essentiel de la réponse cellulaire antivirale
Catherine Bisbal and Tamim Salehzadamédecine/sciences 24 (10) 859 (2008)
https://doi.org/10.1051/medsci/20082410859
Insulin-Like Growth Factor (IGF) family and prostate cancer
C. Gennigens, C. Menetrier-Caux and J.P. DrozCritical Reviews in Oncology/Hematology 58 (2) 124 (2006)
https://doi.org/10.1016/j.critrevonc.2005.10.003
Optimizing the diagnosis of prostate cancer in high‐risk men: the supplementary biomarker approach
Sashi Kommu, Raj Persad, Nick Watkin, Patrick J. Boyd and Ros EelesBJU International 95 (1) 5 (2005)
https://doi.org/10.1111/j.1464-410X.2005.05237.x